سعر نورينوز 50مكجم/جرعة بخاخ للأنف 120 جرعة 2024

Egyptian mometasone furoate 50 mcg/actuation nasal spray, 120 doses (EEPI / Amriya).

• Seasonal allergic or perennial rhinitis (symptoms)Population: Adults and children ≥3 yearsMHRA eMC

• Epistaxis was generally mild/self-limiting and more common than placebo in allergic rhinitis trials; other adverse events were comparable to placebo. Systemic effects of nasal corticosteroids may occur at high doses for prolonged periods.International label, same formulation · MHRA eMC

• Hypersensitivity to mometasone furoate or excipients; untreated localised infection of the nasal mucosa (e.g. herpes simplex); recent nasal surgery or trauma until healing has occurred.International label, same formulation · MHRA eMC

• Use with caution in active/quiescent respiratory tuberculosis or untreated fungal/bacterial/systemic viral infections. Systemic corticosteroid effects may occur with high doses for prolonged periods. Contains benzalkonium chloride which may cause nasal irritation.International label, same formulation · MHRA eMC

• Limited data in pregnancy; animal studies show reproductive toxicity. Do not use in pregnancy unless potential benefit justifies potential risk. Observe infants of mothers who received corticosteroids for hypoadrenalism.International label, same formulation · MHRA eMC
• Unknown whether mometasone furoate is excreted in human milk; decide whether to discontinue breast-feeding or discontinue therapy, taking into account benefit of breast-feeding and of therapy.International label, same formulation · MHRA eMC

• Mometasone furoate: Synthetic corticosteroid with high glucocorticoid-receptor affinity and local anti-inflammatory properties; inhibits leukotriene release and IL-1, IL-5, IL-6 and TNF-alpha synthesis/release (EU SmPC, Atectura).